Ofatumumab (Arzerra 100 mg or 1000 mg concentrate for solution for infusion) is indicated for the treatment of untreated, relapsed, or refractory chronic lymphocytic leukemia (CLL).

2024年12月9日 · Arzerra is used to treat chronic lymphocytic leukemia (CLL), usually in combination with other medicines, such as chlorambucil, or with fludarabine and cyclophosphamide for those with relapsed CLL. Arzerra is given as an intravenous infusion.

ARZERRA (ofatumumab) is a CD20-directed cytolytic monoclonal antibody indicated for the treatment of chronic lymphocytic leukemia (CLL) (1): in combination with chlorambucil, for the treatment of previously untreated patients with CLL for whom fludarabine-based therapy is considered inappropriate.

ARZERRATM (ofatumumab) is a CD20-directed cytolytic monoclonal antibody indicated for the treatment of patients with chronic lymphocytic leukemia (CLL) refractory to fludarabine and alemtuzumab....

2023年9月22日 · Arzerra is a brand (trade) name for ofatumumab which may be used to treat certain patients with chronic lymphocytic leukemia (CLL). Arzerra works by targeting (binding to) the CD20 protein found on the surface of cancerous B cells (including those of …

2024年6月30日 · ARZERRA (ofatumumab) is a CD20-directed cytolytic monoclonal antibody indicated for the treatment of chronic lymphocytic leukemia (CLL) : in combination with chlorambucil, for the treatment of previously untreated patients with CLL for whom fludarabine-based therapy is considered inappropriate.

Arzerra (ofatumumab) is in a class of drugs called anti-CD20-directed monoclonal antibodies. It is used to treat chronic lymphocytic leukemia (CLL) in patients who have further disease after...

2020年5月16日 · Arzerra (ofatumumab) is prescription drug that treats chronic lymphocytic leukemia (CLL) in adults. Learn about uses, side effects, dosage, and more.

2024年3月8日 · Arzerra (ofatumumab) is a brand-name drug prescribed for chronic lymphocytic leukemia (CLL) in some adults. Arzerra comes as an intravenous (IV) infusion given by a healthcare professional. The...

2022年9月21日 · Arzerra (ofatumumab) Injection is a monoclonal antibody used in to treat chronic lymphocytic leukemia. Arzerra is usually given after other medications have been tried without successful treatment of symptoms. What Are Side Effects of Arzerra? Arzerra may cause serious side effects including: